Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

13 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Vital Signs and Physical Examination 12- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 12- Weeks Visits

- 03.12.17 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 12- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination 3- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 3- Weeks Visits

- 03.12.17 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 3- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination 6- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 6- Weeks Visits

- 03.12.17 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 6- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination End of Therapy SirTac NCT02936388 - Vital Signs and Physical Examination End of Therapy

- 28.11.17 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination End of Therapy. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Visit 08 SirTac NCT02936388 - Medical History Visit 08

- 26.11.17 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Visit, quality of life
Study part: Medical History Visit 08. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 06 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 06

- 26.11.17 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 06. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 07 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 07

- 26.11.17 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 07. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 03 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 03

- 26.11.17 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 03. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment SirTac NCT02936388 - Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment

- 26.11.17 - 1 Formular, 2 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and ECOG Screening Day -7 to 0 SirTac NCT02936388 - Vital Signs and ECOG Screening Day -7 to 0

- 26.11.17 - 1 Formular, 2 Itemgruppen, 18 Datenelemente, 1 Sprache
Itemgruppen: vital signs, quality of life
Study part: Vital Signs and ECOG Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Screening Day -14 to 0 SirTac NCT02936388 - Vital Signs and Physical Examination Screening Day -14 to 0

- 26.11.17 - 1 Formular, 2 Itemgruppen, 33 Datenelemente, 1 Sprache
Itemgruppen: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and ECOG Screening Day -7 to 0 SirTac NCT02936388 - Vital Signs and ECOG Screening Day -7 to 0

- 20.11.17 - 1 Formular, 2 Itemgruppen, 18 Datenelemente, 1 Sprache
Itemgruppen: vital signs, quality of life
Study part: Vital Signs and ECOG Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video